Selhorn Ryan J 4
4 · AYTU BIOPHARMA, INC · Filed Oct 7, 2025
Insider Transaction Report
Form 4
Selhorn Ryan J
Chief Financial Officer
Transactions
- Award
Common Stock
2025-10-03+17,500→ 49,743 total - Award
Common Stock
2025-10-03+16,243→ 32,243 total
Footnotes (2)
- [F1]The reporting person was granted fully vested restricted stock in lieu of cash in satisfaction of their annual bonus.
- [F2]Grant of restricted stock, which vest as follows: 1/3 on October 3, 2026, with the remaining restricted stock vesting in 8 equal quarterly installments beginning January 3, 2027.